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Abstract
Background: In order to prepare the field site for future interventions, the prevalence of asymptomatic
Plasmodium falciparum infection was evaluated in a cohort of children living in Brazzaville. Plasmodium falciparum
merozoite surface protein 2 gene (msp2) was used to characterize the genetic diversity and the multiplicity of
infection. The prevalence of mutant P. falciparum chloroquine resistance transporter (pfcrt) allele in isolates was also
determined.
Methods: Between April and June 2010, 313 children below 10 years of age enrolled in the cohort for malaria
surveillance were screened for P. falciparum infection using microscopy and polymerase chain reaction (PCR). The
children were selected on the basis of being asymptomatic. Plasmodium falciparum msp2 gene was genotyped by
allele-specific nested PCR and the pfcrt K76T mutation was detected using nested PCR followed by restriction
endonuclease digestion.
Results: The prevalence of asymptomatic P. falciparum infections was 8.6% and 16% by microscopy and by PCR
respectively. Allele typing of the msp2 gene detected 55% and 45% of 3D7 and FC27 allelic families respectively.
The overall multiplicity of infections (MOI) was 1.3. A positive correlation between parasite density and multiplicity
of infection was found. The prevalence of the mutant pfcrt allele (T76) in the isolates was 92%.
Conclusion: This is the first molecular characterization of P. falciparum field isolates in Congolese children, four
years after changing the malaria treatment policy from chloroquine (CQ) to artemisinin-based combination therapy
(ACT). The low prevalence of asymptomatic infections and MOI is discussed in the light of similar studies
conducted in Central Africa.
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Background
Despite significant reduction in malaria-related morbid-
ity and mortality in the recent past, malaria remains
endemic in the tropics and sub-tropics including sub-
Saharan Africa. About 225 million clinical cases and
781,000 deaths were reported worldwide in 2009,
whereby almost 90% occurred in sub-Saharan Africa [1].
Current malaria control strategies include the use of
insecticide-treated bed nets (ITNs), indoor residual
spraying of insecticide, intermittent preventive treatment
to young children and pregnant women, and early para-
sitological diagnosis and treatment of clinical cases
using artemisinin-based combination therapy (ACT)
[2-4]. Deployment of these strategies has had significant
impact on malaria in many endemic areas.
Although the impact of current malaria control strate-
gies is encouraging, much more remains to be done to
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considered as an additional necessary arsenal. However,
genetic diversity in Plasmodium falciparum is a major
limitation for the successful development of an effective
malaria vaccine, as it influences the level and efficacy of
acquired protective immunity to malaria. Therefore,
screening of the genetic diversity of malaria parasite
populations in different endemic settings is an impor-
tant step towards the development and/or the evaluation
of malaria vaccines [5].
Genotyping of merozoite surface protein-2 (msp2) is the
commonly used method to study the genetic diversity of P.
falciparum. This gene presents polymorphisms in the
number of repeats and sequence type [6]. The analysis of
msp2 alleles involves two major allelic families, FC27 and
3D7. The msp2 gene is also the basis of determining the
multiplicity of infections (MOI) in infected individuals,
which is defined as the number of distinguishable P. falci-
parum clones per infected individual. MOI is a good indi-
cator of acquired immunity or premunition of the
populations living in endemic areas and is also correlated
to the transmission intensity [7,8]. It has been demon-
strated that MOI could be influenced by parasite density
and age [9], and haemoglobin (Hb) type carriage [10].
Makélékélé is an administrative division in the south-
eastern part of Brazzaville (Republic of Congo), and has
been well characterized as a highly endemic area with
perennial malaria transmission [11,12]. However, there is
a paucity of information on the genetic diversity of P. fal-
ciparum populations. Following the replacement of
chloroquine (CQ) with ACT (artesunate-amodiaquine
and artemether-lumefantrine as first and second line
treatment respectively) in 2006 for the treatment of
uncomplicated malaria in the Republic of Congo [13],
CQ drug pressure has since been reduced. In Malawi,
absence of CQ pressure was followed by the re-emer-
gence of CQ-susceptible malaria, based on genotyping of
CQ resistance biomarker, P. falciparum chloroquine
resistance transporter gene (pfcrt)[ 1 4 - 1 6 ] .I nC o n g o
Brazzaville, molecular analysis of the parasite population,
including the CQ resistance pfct K76T mutation has not
been investigated since the change of anti-malarial treat-
ment policy in 2006. Therefore, the present study was
conducted in the semi-urban area of Makélékélé to deter-
mine (i) the prevalence and the multiplicity of P. falci-
parum asymptomatic infection; (ii) the genetic diversity
of the msp2 gene; and (iii) the prevalence of pfcrt K76T
mutation in P. falciparum isolates.
Methods
Study site
The study conducted under the auspices of the Central
Africa Network on Tuberculosis, HIV/AIDS and Malaria
(CANTAM) project, was carried out in three districts of
Makélékélé health division: Ngoko, Kinsana and
Mbouono. These semi-urban divisions with about 6,000
inhabitants are located in the southern part of Brazza-
ville along the Congo River where malaria is transmitted
throughout the year [12]. Plasmodium falciparum is the
main plasmodial species and Anopheles gambiae the
main mosquito vector.
Study population
Children aged one to nine years and permanent resi-
dents of the study area were enrolled in a cohort for
malaria surveillance study (Ndounga et al, unpublished).
From October 2009 to June 2010, a demographic survey
was conducted and 313 children under 10 years were
enrolled. Malaria incidence is 0.9 malaria episode/year/
child. Inclusion criteria were absence of clinical malaria
in the last two weeks and at least one week after enrol-
ment, and with an axillary temperature of < 37.5°C.
Recruitment was done from April to June 2010, and
informed consent was obtained from parents or guar-
dians. Thick and thin blood smears were made from
each child. About 4 ml of whole blood were also col-
lected in EDTA tube for haemoglobin concentration
measurement and DNA extraction. This study was
approved by the Institutional Ethics Committee for
Research on Heath Sciences of the Republic of Congo.
Microscopic examination
Thick and thin blood films were stained with 10%
Giemsa for 15 min and read by two independent com-
petent microscopists to determine malaria species and
the parasite density. Asexual parasites were counted
against 200 leucocytes and expressed as the number of
asexual parasites/μl of blood, assuming the leucocyte
count of 8,000/μl of blood.
Genomic DNA extraction
Genomic DNA was extracted from 200 μl of whole blood
sample using the QIAmp DNA Blood Mini kit (QIAGEN
Gmbh, Hilden, Germany) following the manufacturer’s
instruction. DNA was recovered in 200 μlo fe l u t i o nb u f -
fer provided in the kit and stored at -20°C until use.
msp2 genotyping of plasmodium falciparum isolates
To characterize parasite infection, P. falciparum geno-
typing was performed using a nested PCR for msp2 cen-
tral region, which comprises repeats of varying lengths.
The FC27 and 3D7 allele families were analysed. The
specific oligonucleotide primers and PCR conditions
were as previously described by Ntoumi et al [17].
Pfcrt K76T PCR-typing
The nested PCR followed by restriction enzyme diges-
tion PCR reactions were used to genotype the Lysine to
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Mayengue et al [18], Djimde et al [19] and Mayor et al
[20]. All isolates successfully amplified using msp2 PCR
were assayed with the pfcrt PCR.
Sickle cell trait
b-globin genotypes HbAA, HbAS and HbSS were deter-
mined using allele specific PCR method as described by
Wu et al [21].
Data analysis
The prevalence of FC27 and 3D7 alleles was determined
as the presence of PCR products for each type in the
total number of amplified bands for the corresponding
locus. The MOI was determined as the number of differ-
ent msp2 genotypes per isolate, and the mean MOI was
calculated as the total number of detected Plasmodium
falciparum msp2 genotypes/total number of infected
children [18]. The msp2 allelic frequency represents the
ratio of one specific allele out of the total number of
alleles identified in the isolates. The polyclonality (per-
centage of isolates with more than one amplified PCR
fragment) was estimated for each group. Similarly, pro-
portions of wild and mutant pfcrt alleles were calculated
as the ratio of each allele type out of the total of P. falci-
parum positive samples. Statistical analysis was done
using XLSTAT software (Version 2011.2.08). The chi-
square test was used to compare quantitative variables
such as parasite prevalence and MOI between different
groups. The Spearman’s rank correlation coefficient was
calculated to assess association between MOI and para-
site density. Differences were considered statistically sig-
nificant at P values < 0.05.
Results
Baseline demographic data and parasitological indexes
A total of 313 children aged from one to nine years (mean
age: 4.4 ± 2.5 years) were enrolled in the study. Sickle cell
trait was present in 58 (18.5%) of them. The haemoglobin
levels were distributed into 3 categories: normal ≥ 12.0 g/
dl (23.3% of children), moderate anemia 11.9 g/dl-7.0 g/dl
(72.2%) and severe anemia < 7 g/dl (1.3%).
The prevalence of asymptomatic parasitaemia detected
microscopically was 8.6%, P. falciparum being the only
infecting specie. The parasite density ranged from 62 to
16,090 parasites/μl and a geometric mean density of 3,421
parasites/μl. Through PCR amplification of msp2 gene,
P. falciparum infection was detected in 16% of the isolates
(Table 1).
The prevalence of infection (by microscopy and PCR)
varied according to the age of children (P < 0.05), being
highest in the seven to nine years age group (14 and
26% respectively), followed by four to six years (11 and
17%), and one to three years age group (3.5 and 7%).
Merozoite surface protein 2 genetic diversity
Alleles were determined by size and family type. Allele
typing showed the highly polymorphic nature of P. fal-
ciparum isolates. Both 3D7 and FC27 families were
identified with 8 and 10 different alleles respectively
(Figure 1). The proportion of isolates having only 3D7
and FC27 alleles was 23/51 (45%) and 18/51 (35%)
respectively. Both allelic families were found in 7/51
(14%) of the isolates. Six per cent (6%) of the isolates
were not identified to any of the 3D7 or FC27 allelic
family despite being repeatedly amplified (Table 2).
This might be due to a mutation in the annealing
region of the primers.
Multiplicity of plasmodium falciparum infection
In this study, 74% of the infections analysed consisted of
as i n g l emsp2 genotype, 22% were double infection and
4% triple. The overall MOI was 1.3 and similar in all
age groups. The proportion of samples with more than
one clone was higher in both one to three and four to
six years age groups (33.3 and 27.8% respectively) com-
pared to the seven to nine years olds group (19%)
(Table 3). However, the difference was not statistically
significant.
Table 1 Demographic data and parasitological indexes of
the study population
Parameters Values
Mean age (year) 4.4 ± 2.5
Age range 1-9
Sex ratio (M/F) 1.1 (168/146)
Mean axillary temperature (°C) 36.5 ± 0.3
Axillary temperature range (°C) 36-37.4
Mean hematocrit (g/dl) 10.0
Hb ≥ 12.0 g/dl n(%) 73 (23.3%)
Hb 7.0 g/dl -11.9 g/dl n(%) 226 (72.2%)
Hb < 7.0 g/dl n(%) 4 (1.3%)
Hb not determined 10 (3.2%)
HbAA, n(%) 255 (81.5%)
HbAS, n(%) 58 (18.5%)
HbSS, n(%) 0
P. falciparum prevalence, n(%)
Microscopy 27 (8.6%)
PCR 51 (16.0%)
Geometric mean parasite density (p/μl) 3,421
Parasite density range (p/μl) 62-16,090
Mean MOI 1.3
MOI-range 1-3
pfcrt K76T prevalence n(%)*
Wild type 4 (8%)
Mutant type 47 (92%)
Number of individuals 313
* Prevalence determined among PCR positive samples
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ence on MOI. The prevalence of multiple infections in
AA group was 19% compared with 27% in AS group, and
this difference was not significant (Table 3). Nonetheless,
a significant positive association was found between
P. falciparum parasite density and MOI (Spearman rank
coefficient = 0.4489, P = 0.0278) (Figure 2).
Prevalence of pfcrt K76T mutation
Genotyping of the pfcrt gene showed that 47 isolates out
of 51 (92%) produced the expected 134 bp amplicon,
suggesting the presence of T76 mutation. Four isolates
(8%) with the wild type were found (Table 1).
Discussion
In the Republic of Congo, less attention had been put on
the investigation of the genetic diversity of P. falciparum
among asymptomatic parasite carriers. Besides, this ana-
lysis is necessary to develop strategies for malaria control
including the design of malaria vaccines interventions.
The current study is the first of its kind to evaluate
genetic diversity of P. falciparum isolates circulating
among children younger than 10 years old, and to pre-
sent the molecular analysis of pfcrt gene since the repla-
cement of chloroquine with ACT as the first line anti-
malarial drug in Congo Brazzaville.
The prevalence of P. falciparum carriage of 8.6%
(microscopically) and 16% (by PCR) is low compared to
those reported previously from other malaria endemic
areas [9,10,22]. However, these findings are in line with
the results of a recent study conducted in Gabon that
showed a relatively low prevalence of asymptomatic P.
falciparum infection of 5% by microscopy among young
children [23]. In the recent past, a large number of ITNs
were available to children under five years of age and to
pregnant women in the Republic of Congo. The observed
low prevalence could be attributed to the wide use of the
ITNs. Further investigations involving more children and
adults would be of great importance to confirm this
finding.
Allele-specific genotyping of msp2 has shown that
P. falcuparum population in this part of the Republic of
Congo have a high genetic diversity. Dispite the fact
that a high proportion of isolates (74%) carried one
Figure 1 Distribution of P. falciparum 3D7 and FC27 msp2 alleles.
Table 2 Genetic diversity of P. falciparum msp2 gene
No. of samples Prevalence (%) Fragment size (bp) Total No. of alleles
a Allelic frequency
b
3D7 23 45 250-450 38 55
FC27 18 35 280-680 31 45
FC27 + 3D7 7 14
Non identified 3 6
Total 51 100 69 100
No. Number
a Total number of alleles is the number of different msp2 alleles distinguished by the size and the family type (3D7 and FC27)
b Allelic frequency is defined as the ratio of 3D7 or FC27 alleles out of the total number of msp2 alleles
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genotypes, different types of both 3D7 and FC27 alleles
were found. The proportion of 3D7 alleles (55%) was
slightly high compared with that of FC27 (45%). This is
similar to findings in Papua New Guinea [22].
The MOI (number of concurrent msp2 genotypes in
individual infections) ranged from 1 to 3. The mean MOI
of 1.3 is relatively low compared to those reported in
Gabon [24], Senegal [9,25], and Ghana [26] in asympto-
matic cases. This might be explained by the fact that diver-
sity of P. falciparum population differs according to the
geographic location, and the level of transmission [27,28].
In the same study area [29], the MOI in isolates from
symptomatic children was 2.2. The interpretation of this
increase in the mean number of parasite genotype/infected
child could be the presence of the uncontrolled strain
causing the symptoms.
Age is one of the suggested important factors involved
in the acquisition of immunity against P. falciparum and
influences MOI [9]. On the contrary, these results show
that age has no effect on MOI. The absence of influence
of age on MOI has also been previously reported in the
same area among P. falciparum symptomatic children by
Pembe et al [29].
Previous studies on association between MOI and para-
site densities showed that high parasite densities increase
the probability of detecting concurent clones in an indivi-
dual [30,31]. Expectedly, a positive correlation between
MOI and parasite density was found in the present study.
The impact of sickle cell trait on MOI in this study is
different from findings in Gabon by Ntoumi et al [10], in
which, a correlation between sickle cell trait and MOI
was found. However, this observation corroborates
reports from Senegale by Konate et al [32] and Vafa et al
[9] whereby no correlation was found. These discrepan-
cies can be explained by differences in age ranges of the
study population and the number of individuals with
sickle cell trait enrolled.
The prevalence of pfcrt K76T was also assessed, the
mutation associated with CQ resistance. It was anticipated
that the sensitivity of the parasite to CQ may have been
restored several years after its withdrawal as was the case
Table 3 Comparison of the parasite prevalence, parasite density and the MOI in different age groups and
haemoglobin (Hb) phenotypes
Age groups P Hb type P
1-3 4-6 7-9 AA AS
N = 137 N = 96 N = 80 N = 255 N = 58
Parasite prevalence n(%)
Microscopy 5 (3.5%) 11 (11%) 11(14%) 0.018 19 (7.5%) 8 (13.5%) NS
PCR 12 (8.8%) 18 (17%) 21(26%) 0.002 40 (15.5%) 11 (19%) NS
Geometric mean parasite density (p/μl) 1,246 3,442 3,024 NS 4,052 2,081 NS
Mean MOI 1.3 1.3 1.2 NS 1.3 1.4 NS
Proportion of multiple infections* 4/12(33.3%) 5/18(27.8%) 4/21(19%) NS 8/40(19%) 3/11(27%) NS
* Proportion of multiple infections in PCR positive samples, NS non significant
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P = 0.0278
Figure 2 Correlation of msp2 multiplicity of infection and mean Plasmodium falciparum parasite density Spearman rank coefficient =
0.4489, P = 0.0278.
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tant molecular marker surveillance tool that can contri-
bute to the evaluation of local parasite strains sensitivity to
CQ in addition to in vitro studies [33], was 98% in Congo
before withdrawal of CQ [18]. Almost five years later, this
study shows that the prevalence of this mutation remains
high, 92%. This observation is similar to a recent report by
Efunshile et al in Nigeria [34]. Therefore, CQ cannot be
re-introduced in Congo now despite its many advantages
over other anti-malarials.
Conclusion
In summary, these findings shows that multiplicity of
infection which is low in Congolese children with asymp-
tomatic P. falciparum infection increases with parasite
density. The prevalence of the mutant pfcrt allele remains
extremely high in the study area. Further investigations
with larger sample size in different zones of the country
would be needed to confirm these observations.
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